Wouter de Herder

About Wouter de Herder

Wouter de Herder, With an exceptional h-index of 104 and a recent h-index of 61 (since 2020), a distinguished researcher at Erasmus Universiteit Rotterdam, specializes in the field of Endocrinology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Approach to the patient: insulinoma

[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors …

Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous …

Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature

Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide …

Glucagon and insulin: 100 years young

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN

What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators

Wouter de Herder Information

University

Position

Professor of endocrine Oncology ErasmusMC Rotterdam the Netherlands

Citations(all)

42941

Citations(since 2020)

14449

Cited By

34604

hIndex(all)

104

hIndex(since 2020)

61

i10Index(all)

379

i10Index(since 2020)

247

Email

University Profile Page

Google Scholar

Wouter de Herder Skills & Research Interests

Endocrinology

Top articles of Wouter de Herder

Approach to the patient: insulinoma

The Journal of Clinical Endocrinology & Metabolism

2024/4

[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors …

2024/1/20

Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous …

Trials

2024/1/16

Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature

European Journal of Cancer

2024/1/1

Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide …

Trials

2024/12

Glucagon and insulin: 100 years young

Endocrine-Related Cancer

2024/5/1

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN

2024/4/1

What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators

2023/12/1

The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports

2023/12

Neuroendocrine neoplasia

2023/10/30

Wouter De Herder
Wouter De Herder

H-Index: 58

132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN–an EORTC-SPECTA and EURACAN study

Annals of Oncology

2023/10/1

THU071 Key Device Attributes For Injectable SRL Therapy In Acromegaly And NETs To Aid Clinical Decision Making

Journal of the Endocrine Society

2023/10

Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours

Advances in Therapy

2023/10

One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones

2023/9/1

Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview

2023/8

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Endocrine-Related Cancer

2023/8/1

A bronze statue of the acromegalic giant Rigardus Rijnhout

Journal of Endocrinological Investigation

2023/6/17

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion

Frontiers in Endocrinology

2023/6/14

Effective strategies for adequate control of hormonal secretion in functioning neuroendocrine neoplasms

2023/6/7

Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST

Journal of neuroendocrinology

2023/6

See List of Professors in Wouter de Herder University(Erasmus Universiteit Rotterdam)